Literature DB >> 12197815

Hepatitis C-related discrimination in healthcare. Report of the Third Australasian Conference on Hepatitis C, Melbourne, March 202.

Carla J Treloar1, Max N Hopwood, Stuart K Loveday.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12197815     DOI： 10.5694/j.1326-5377.2002.tb04753.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  3 in total

1.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

2.  Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.

Authors:  Corrine E Munoz-Plaza; Shiela Strauss; Janetta Astone-Twerell; Don Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Journal:  Int J Drug Policy       Date:  2007-08-06

3.  Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study.

Authors:  Joshua A Barocas; Meghan B Brennan; Shawnika J Hull; Scott Stokes; John J Fangman; Ryan P Westergaard
Journal:  Harm Reduct J       Date:  2014-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.